Theranos Lays Off Most Of Its Workforce
PYMNTS
APRIL 11, 2018
The move comes as CEO Elizabeth Holmes agreed to settle with the Securities and Exchange Commission (SEC) over “massive fraud” charges lodged against the company. However, the reality, according to the SEC, was that the company’s blood analyzer technology could only do a small number of tests.
Let's personalize your content